CAPTIVATE is an international, multi-centre, Phase III, adaptive, platform, randomised controlled trial in people with chronic kidney disease (CKD).
CAPTIVATE aims to find the best treatment, or combination of treatments, that slow the progression of CKD so that fewer people develop kidney failure.
CAPTIVATE provides a research platform that allows many treatment-related questions to be answered within a common trial set-up.
Age ≥ 18 years
Known chronic kidney disease from any cause (eGFR ≥25 mL/min/1.73m2)
Currently receiving standard of care treatment according to treating physician
Eligible for randomisation in at least one recruiting domain-specific appendix
Planned to commence kidney replacement therapy or kidney transplant surgery in next 6 months
Life expectancy less than 6 months